Paysign (NASDAQ:PAYS) reported what executives described as the strongest start to a year in the company’s history, with first-quarter 2026 revenue rising 50.8% year over year to $28 million and profitability...
Mix Shift Continues to Deliver Expansion in Gross and Operating Margin Strong Balance Sheet Enables Continued Investment for Profitable Growth
Barchart Research What to Expect from PAYS Earnings PAYS Generated May 11, 2026 Current Price $6.69 EPS Estimate $$0.16 Consensus Rating Strong Buy Average Move 11.25% Paysign's Patient Affordability Momentum...
Paysign, Inc. (NASDAQ: PAYS ), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment...
Mix Shift Drives Gross and Operating Margin Expansion Strong Balance Sheet Enables Continued Investment for Profitable Growth
Paysign, Inc. (NASDAQ: PAYS ), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment...
Paysign, Inc. (NASDAQ: PAYS ), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment...
Dynamic Business Rules Demonstrates the Company’s Advanced Capabilities in Mitigating Copay Maximizers, Exiting 2025 With 131 Active Programs
Paysign, Inc. (NASDAQ: PAYS ), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment...
Delivered strong performance with record revenue and improved profitability Third quarter 2025 total revenues of $21.60 million, up 41.6% from third quarter...